Atomistry » Chlorine » PDB 6tdq-6tma » 6te6
Atomistry »
  Chlorine »
    PDB 6tdq-6tma »
      6te6 »

Chlorine in PDB 6te6: Crystal Structure of DOT1L in Complex with An Inhibitor (Compound 3).

Enzymatic activity of Crystal Structure of DOT1L in Complex with An Inhibitor (Compound 3).

All present enzymatic activity of Crystal Structure of DOT1L in Complex with An Inhibitor (Compound 3).:
2.1.1.43;

Protein crystallography data

The structure of Crystal Structure of DOT1L in Complex with An Inhibitor (Compound 3)., PDB code: 6te6 was solved by C.Scheufler, F.Stauffer, C.Be, H.Moebitz, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 45.77 / 1.98
Space group P 63
Cell size a, b, c (Å), α, β, γ (°) 158.540, 158.540, 74.230, 90.00, 90.00, 120.00
R / Rfree (%) 17.8 / 20.1

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of DOT1L in Complex with An Inhibitor (Compound 3). (pdb code 6te6). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the Crystal Structure of DOT1L in Complex with An Inhibitor (Compound 3)., PDB code: 6te6:
Jump to Chlorine binding site number: 1; 2;

Chlorine binding site 1 out of 2 in 6te6

Go back to Chlorine Binding Sites List in 6te6
Chlorine binding site 1 out of 2 in the Crystal Structure of DOT1L in Complex with An Inhibitor (Compound 3).


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of DOT1L in Complex with An Inhibitor (Compound 3). within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl401

b:33.6
occ:1.00
CL1 A:N4W401 0.0 33.6 1.0
C23 A:N4W401 1.8 32.3 1.0
C24 A:N4W401 2.7 28.7 1.0
C22 A:N4W401 2.8 30.2 1.0
CG A:TYR312 3.5 30.1 1.0
CB A:MET147 3.7 28.6 1.0
CD2 A:TYR312 3.7 30.9 1.0
CG A:MET147 3.7 30.7 1.0
CB A:TYR312 3.7 26.2 1.0
CE2 A:PHE239 3.9 29.4 1.0
CD1 A:TYR312 4.0 33.8 1.0
C19 A:N4W401 4.0 27.5 1.0
C21 A:N4W401 4.1 29.6 1.0
CE2 A:TYR312 4.3 31.7 1.0
CG A:LEU143 4.4 30.1 1.0
O A:LEU143 4.5 26.8 1.0
CE1 A:TYR312 4.5 32.6 1.0
C20 A:N4W401 4.6 26.5 1.0
CD2 A:PHE239 4.6 27.6 1.0
CZ A:PHE239 4.6 28.8 1.0
CZ A:TYR312 4.7 36.0 1.0
CD2 A:LEU143 4.7 29.3 1.0
CB A:VAL267 4.8 31.0 1.0
CG2 A:VAL267 4.8 31.4 1.0
C A:LEU143 4.9 27.6 1.0
CE A:MET147 5.0 32.0 1.0

Chlorine binding site 2 out of 2 in 6te6

Go back to Chlorine Binding Sites List in 6te6
Chlorine binding site 2 out of 2 in the Crystal Structure of DOT1L in Complex with An Inhibitor (Compound 3).


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 2 of Crystal Structure of DOT1L in Complex with An Inhibitor (Compound 3). within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Cl401

b:44.4
occ:1.00
CL1 B:N4W401 0.0 44.4 1.0
C23 B:N4W401 1.8 39.9 1.0
C24 B:N4W401 2.7 38.6 1.0
C22 B:N4W401 2.8 38.0 1.0
CG B:TYR312 3.5 42.2 1.0
CB B:MET147 3.6 37.6 1.0
CG B:MET147 3.6 40.7 1.0
CD2 B:TYR312 3.7 43.8 1.0
CB B:TYR312 3.7 40.5 1.0
CE2 B:PHE239 3.9 37.2 1.0
CD1 B:TYR312 4.0 44.4 1.0
C21 B:N4W401 4.1 39.5 1.0
C19 B:N4W401 4.1 36.7 1.0
CE2 B:TYR312 4.2 44.5 1.0
CG B:LEU143 4.4 35.9 1.0
O B:LEU143 4.5 34.0 1.0
CE1 B:TYR312 4.5 46.1 1.0
C20 B:N4W401 4.6 38.0 1.0
CD2 B:PHE239 4.6 35.4 1.0
CZ B:PHE239 4.6 35.0 1.0
CZ B:TYR312 4.6 48.7 1.0
CD2 B:LEU143 4.8 39.4 1.0
CB B:VAL267 4.8 44.0 1.0
CG2 B:VAL267 4.8 44.0 1.0
C B:LEU143 4.9 33.8 1.0
CE B:MET147 4.9 39.9 1.0
CA B:MET147 5.0 35.7 1.0

Reference:

F.Stauffer, A.Weiss, C.Scheufler, H.Mobitz, C.Ragot, K.S.Beyer, K.Calkins, D.Guthy, M.Kiffe, B.Van Eerdenbrugh, R.Tiedt, C.Gaul. New Potent DOT1L Inhibitors Forin Vivoevaluation in Mouse. Acs Med.Chem.Lett. V. 10 1655 2019.
ISSN: ISSN 1948-5875
PubMed: 31857842
DOI: 10.1021/ACSMEDCHEMLETT.9B00452
Page generated: Sat Jul 12 20:06:51 2025

Last articles

Fe in 2YXO
Fe in 2YRS
Fe in 2YXC
Fe in 2YNM
Fe in 2YVJ
Fe in 2YP1
Fe in 2YU2
Fe in 2YU1
Fe in 2YQB
Fe in 2YOO
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy